Adlyxin is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Limitations of Use:
Adlyxin is a GLP‐1 receptor agonist. Adlyxin increases glucose‐dependent insulin release, decreases glucagon secretion, and slows gastric emptying.
if enrolled in the Sanofi Rx Savings program and taking select Sanofi diabetes products.
Pay no more than $15 if new to the program.*
The Adlyxin COACH program provides information and personalized support for patients who have been prescribed Adlyxin.